{"id":2233,"date":"2015-04-29T07:28:14","date_gmt":"2015-04-29T07:28:14","guid":{"rendered":"http:\/\/www.neb-online.de\/?page_id=2233"},"modified":"2020-07-31T09:36:38","modified_gmt":"2020-07-31T07:36:38","slug":"glycobiology","status":"publish","type":"page","link":"https:\/\/www.neb-online.de\/en\/glycobiology\/","title":{"rendered":"Glycobiology"},"content":{"rendered":"

[vc_row][vc_column][vc_basic_grid post_type=”post” max_items=”10″ element_width=”6″ gap=”15″ item=”4123″ taxonomies=”123″ grid_id=”vc_gid:1596180983413-d42fe07a-9da6-1″][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]The relevance of glycobiology goes beyond the importance for basic studies of cell biology. Currently, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater than $20 billion market (1-4).<\/p>\n

A very important set of therapeutic glycoproteins are recombinant monoclonal antibodies<\/a> (rMAbs). They can effectively inhibit TNF-\u03b1 and thus control the symptoms of rheumatoid arthritis, multiple sclerosis and other autoimmune diseases. Oncological applications include the use of rMAbs to target malignant cells to prevent tumor proliferation.<\/p>\n

Recent progress in chemical synthesis and bioengineering resulted in the development of many carbohydrate-based vaccines, some of which also have applications in cancer treatment. Finally, it must be mentioned that one of the oldest drug agents to date is Heparin<\/a>, a proteoglycan that is still widely used to successfully treat a broad range of conditions.[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]References<\/em><\/p>\n

1. Jacobs PP, Callewaert N. (2009)\u00a0Curr Mol Med. 9(7):774-800. PMID:\u00a019860659
\n<\/a>2. Hossler P, Khattak SF, Li ZJ. (2009)\u00a0Glycobiology. 19(9):936-49. PMID:\u00a019494347
\n<\/a>3. Cosmi B, Palareti G. (2012)\u00a0Thromb Res.\u00a0129(3):388-91\u00a0PMID:\u00a022137740
\n<\/a>4. Lepenies B, Seeberger PH. (2010)\u00a0Immunopharmacol Immunotoxicol.\u00a032(2):196-207. PMID:\u00a020141495<\/a><\/em>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_basic_grid post_type=”post” max_items=”10″ element_width=”6″ gap=”15″ item=”4123″ taxonomies=”123″ grid_id=”vc_gid:1596180983413-d42fe07a-9da6-1″][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]The relevance of glycobiology goes beyond the importance for basic studies of cell biology. Currently, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater than $20 billion market (1-4). A very important set of therapeutic glycoproteins are recombinant monoclonal antibodies (rMAbs). They can effectively inhibit TNF-\u03b1 and thus… Read more »<\/a><\/p>\n","protected":false},"author":2,"featured_media":40771,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"closed","template":"page-sidebar.php","meta":{"footnotes":""},"class_list":["post-2233","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nGlycobiology - New England Biolabs GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neb-online.de\/en\/glycobiology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glycobiology - New England Biolabs GmbH\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_basic_grid post_type=”post” max_items=”10″ element_width=”6″ gap=”15″ item=”4123″ taxonomies=”123″ grid_id=”vc_gid:1596180983413-d42fe07a-9da6-1″][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]The relevance of glycobiology goes beyond the importance for basic studies of cell biology. Currently, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater than $20 billion market (1-4). A very important set of therapeutic glycoproteins are recombinant monoclonal antibodies (rMAbs). They can effectively inhibit TNF-\u03b1 and thus... Read more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neb-online.de\/en\/glycobiology\/\" \/>\n<meta property=\"og:site_name\" content=\"New England Biolabs GmbH\" \/>\n<meta property=\"article:modified_time\" content=\"2020-07-31T07:36:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"760\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/\",\"url\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/\",\"name\":\"Glycobiology - New England Biolabs GmbH\",\"isPartOf\":{\"@id\":\"https:\/\/www.neb-online.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg\",\"datePublished\":\"2015-04-29T07:28:14+00:00\",\"dateModified\":\"2020-07-31T07:36:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neb-online.de\/en\/glycobiology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage\",\"url\":\"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg\",\"contentUrl\":\"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg\",\"width\":760,\"height\":200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.neb-online.de\/en\/glycobiology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.neb-online.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glycobiology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neb-online.de\/#website\",\"url\":\"https:\/\/www.neb-online.de\/\",\"name\":\"New England Biolabs GmbH\",\"description\":\"Enabling Technologies in the Life Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neb-online.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glycobiology - New England Biolabs GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neb-online.de\/en\/glycobiology\/","og_locale":"en_US","og_type":"article","og_title":"Glycobiology - New England Biolabs GmbH","og_description":"[vc_row][vc_column][vc_basic_grid post_type=”post” max_items=”10″ element_width=”6″ gap=”15″ item=”4123″ taxonomies=”123″ grid_id=”vc_gid:1596180983413-d42fe07a-9da6-1″][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]The relevance of glycobiology goes beyond the importance for basic studies of cell biology. Currently, glycoprotein and carbohydrate-based drugs and therapeutics represent a greater than $20 billion market (1-4). A very important set of therapeutic glycoproteins are recombinant monoclonal antibodies (rMAbs). They can effectively inhibit TNF-\u03b1 and thus... Read more »","og_url":"https:\/\/www.neb-online.de\/en\/glycobiology\/","og_site_name":"New England Biolabs GmbH","article_modified_time":"2020-07-31T07:36:38+00:00","og_image":[{"width":760,"height":200,"url":"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg","type":"image\/jpeg"}],"twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/","url":"https:\/\/www.neb-online.de\/en\/glycobiology\/","name":"Glycobiology - New England Biolabs GmbH","isPartOf":{"@id":"https:\/\/www.neb-online.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage"},"image":{"@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage"},"thumbnailUrl":"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg","datePublished":"2015-04-29T07:28:14+00:00","dateModified":"2020-07-31T07:36:38+00:00","breadcrumb":{"@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neb-online.de\/en\/glycobiology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/#primaryimage","url":"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg","contentUrl":"https:\/\/www.neb-online.de\/wp-content\/uploads\/2015\/04\/NEB_glykobiologie_header_760px.jpg","width":760,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.neb-online.de\/en\/glycobiology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.neb-online.de\/en\/"},{"@type":"ListItem","position":2,"name":"Glycobiology"}]},{"@type":"WebSite","@id":"https:\/\/www.neb-online.de\/#website","url":"https:\/\/www.neb-online.de\/","name":"New England Biolabs GmbH","description":"Enabling Technologies in the Life Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neb-online.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/pages\/2233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/comments?post=2233"}],"version-history":[{"count":10,"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/pages\/2233\/revisions"}],"predecessor-version":[{"id":23886,"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/pages\/2233\/revisions\/23886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/media\/40771"}],"wp:attachment":[{"href":"https:\/\/www.neb-online.de\/en\/wp-json\/wp\/v2\/media?parent=2233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}